ASCLF (Ascletis Pharma) Days Payable : 82.73 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ascletis Pharma Days Payable?

Ascletis Pharma's average Accounts Payable for the six months ended in Dec. 2024 was $0.03 Mil. Ascletis Pharma's Cost of Goods Sold for the six months ended in Dec. 2024 was $0.08 Mil. Hence, Ascletis Pharma's Days Payable for the six months ended in Dec. 2024 was 82.73.

The historical rank and industry rank for Ascletis Pharma's Days Payable or its related term are showing as below:

ASCLF' s Days Payable Range Over the Past 10 Years
Min: 9.46 Med: 22.96 Max: 408.63
Current: 258.52

During the past 9 years, Ascletis Pharma's highest Days Payable was 408.63. The lowest was 9.46. And the median was 22.96.

ASCLF's Days Payable is ranked better than
67.85% of 703 companies
in the Biotechnology industry
Industry Median: 119.64 vs ASCLF: 258.52

Ascletis Pharma's Days Payable increased from Dec. 2023 (30.45) to Dec. 2024 (82.73). It may suggest that Ascletis Pharma delayed paying its suppliers.

Ascletis Pharma Days Payable Historical Data

The historical data trend for Ascletis Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascletis Pharma Days Payable Chart

Ascletis Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

22.22

9.46

9.93

23.04

231.17

Ascletis Pharma Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial												13.13	117.77	30.45	-	82.73

Competitive Comparison of Ascletis Pharma's Days Payable

For the Biotechnology subindustry, Ascletis Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascletis Pharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascletis Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Ascletis Pharma's Days Payable falls into.

Save Embed

;

Save Embed

;

Ascletis Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ascletis Pharma's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (0.091	+	0.004)	/	2 )	/	0.075	*	365
=	0.0475					/	0.075	*	365
=	231.17

Ascletis Pharma's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0.064	+	0.004)	/	2 )	/	0.075	*	365 / 2
=	0.034					/	0.075	*	365 / 2
=	82.73

Ascletis Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of Ascletis Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascletis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (OTCPK:ASCLF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

01672:Hong Kong 2VJ:Germany

Address

198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200

Website

https://www.ascletis.com

Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. Ritonavir tablets, GANOVO, and ASCLEVIR. It also has other drug candidates in its pipeline in their different stages of development such as ASC22, ASC10, ASC11, and ASC40 among others. Geographically, it operates in Mainland China and other countries.